Ganga Pharmaceuticals Ltd - 539680 - Statement Of Investor Complaints For The Quarter Ended March 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- PRITI KOTHARI BHAIYADesignation :- Company Secretary and Compliance Officer Ganga Pharmaceuticals Ltd - 539680 - Closure of Trading Window
Pursuant to SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018 for the time being in force and in terms of the Code of Conduct adopted by the Company, the trading window for dealing in the securities of the Company will remain closed for all the Directors, Promoters, Designated Employees and Connected Persons from April 01, 2022 till 48 hours after the declaration of Audited Financial Results of the Company for the half year and financial year ended on March 31, 2022. Ganga Pharmaceuticals Ltd - 539680 - Shareholding for the Period Ended December 31, 2021
Ganga Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click here Ganga Pharmaceuticals Ltd - 539680 - Statement Of Investor Complaints For The Quarter Ended December 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- BHARAT BRIJMOHAN SHARMADesignation :- Managing Director / Whole Time Director Ganga Pharmaceuticals Ltd - 539680 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliances - Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 Ganga Pharmaceuticals Ltd - 539680 - Clear Copy Of Financial Result For The Half Year Ended September 30, 2021
With reference to above and with respect to the mail dated December 09, 2021, clear copy of the Financial result for the half year ended September 30, 2021 is attached herewith. Ganga Pharmaceuticals Ltd - 539680 - Un-Audited Financial Result For The Half Year Ended September 30, 2021
Approval of Un-audited Financial Result for the half year ended September 30, 2021 Ganga Pharmaceuticals Ltd - 539680 - Board Meeting Intimation for Unaudited Financial Results For The Half Year Ended September 30, 2021
Ganga Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2021 ,inter alia, to consider and approve the unaudited Financial Results of the Company for the half year ended on September 30, 2021. Ganga Pharmaceuticals Ltd - 539680 - Shareholding for the Period Ended September 30, 2021
Ganga Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click here Ganga Pharmaceuticals Ltd - 539680 - Statement Of Investor Complaints For The Quarter Ended September 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Bharat SharmaDesignation :- Managing Director / Whole Time Director